The Cyclin-Dependent Kinase Inhibitors Olomoucine and Roscovitine Arrest Human Fibroblasts in G1 Phase by Specific Inhibition of CDK2 Kinase Activity
- 25 November 1998
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 245 (1), 8-18
- https://doi.org/10.1006/excr.1998.4216
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Cancer Cell CyclesScience, 1996
- Multiple modes of ligand recognition: Crystal structures of cyclin‐dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenineProteins-Structure Function and Bioinformatics, 1995
- Cyclins and cyclin-dependent kinases: a biochemical viewBiochemical Journal, 1995
- Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycleBioEssays, 1995
- Principles of CDK regulationNature, 1995
- Cellular effects of olomoucine, an inhibitor of cyclin‐dependent kinasesBiology of the Cell, 1995
- Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitionsFEBS Letters, 1994
- Inhibition of Cyclin‐Dependent Kinases by Purine AnaloguesEuropean Journal of Biochemistry, 1994
- Cyclins and cyclin-dependent kinases: take your partnersTrends in Biochemical Sciences, 1993
- Control of the yeast cell cycle by the Cdc28 protein kinaseCurrent Opinion in Cell Biology, 1993